X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (68) 68
oncology (61) 61
index medicus (53) 53
carcinoma, renal cell - drug therapy (47) 47
kidney neoplasms - drug therapy (47) 47
male (42) 42
carcinoma, renal cell (40) 40
middle aged (40) 40
female (38) 38
aged (35) 35
cancer (34) 34
kidney neoplasms - pathology (32) 32
renal cell carcinoma (28) 28
adult (24) 24
antineoplastic agents - therapeutic use (24) 24
sunitinib (23) 23
care and treatment (21) 21
interferon-alpha (21) 21
metastasis (21) 21
survival (20) 20
vascular endothelial growth factor (20) 20
carcinoma, renal cell - secondary (19) 19
bevacizumab (18) 18
research (18) 18
carcinoma, renal cell - pathology (16) 16
endothelial growth-factor (16) 16
immunotherapy (16) 16
sorafenib (16) 16
treatment outcome (16) 16
disease-free survival (15) 15
drug therapy (15) 15
indoles - therapeutic use (15) 15
neoplasm metastasis (15) 15
pyrroles - therapeutic use (15) 15
analysis (14) 14
article (14) 14
carcinoma, renal cell - mortality (14) 14
kidney neoplasms - mortality (14) 14
patient outcomes (14) 14
therapy (14) 14
abridged index medicus (13) 13
medicine & public health (13) 13
aged, 80 and over (12) 12
urology & nephrology (12) 12
antimitotic agents (11) 11
antineoplastic agents (11) 11
antineoplastic agents - adverse effects (11) 11
carcinoma, renal cell - therapy (11) 11
dendritic cells (11) 11
survival rate (11) 11
vascular endothelial growth factor a - antagonists & inhibitors (11) 11
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
angiogenesis inhibitors - therapeutic use (9) 9
dosage and administration (9) 9
immunology (9) 9
indoles - administration & dosage (9) 9
kidney cancer (9) 9
kidney neoplasms - therapy (9) 9
prognosis (9) 9
pyrroles - administration & dosage (9) 9
targeted therapy (9) 9
tyrosine kinase inhibitor (9) 9
vegf (9) 9
chemotherapy (8) 8
efficacy (8) 8
hematology, oncology and palliative medicine (8) 8
kaplan-meier estimate (8) 8
niacinamide - analogs & derivatives (8) 8
pazopanib (8) 8
time factors (8) 8
tumors (8) 8
angiogenesis (7) 7
animals (7) 7
antibodies, monoclonal - therapeutic use (7) 7
axitinib (7) 7
cancer therapies (7) 7
carcinoma, renal cell - genetics (7) 7
carcinoma, renal cell - immunology (7) 7
development and progression (7) 7
hypertension (7) 7
indoles - adverse effects (7) 7
interleukin-2 (7) 7
kidney neoplasms - genetics (7) 7
kidney neoplasms - immunology (7) 7
phase-ii (7) 7
progression-free survival (7) 7
proportional hazards models (7) 7
pyrroles - adverse effects (7) 7
trial (7) 7
tumor-suppressor gene (7) 7
antibodies, monoclonal, humanized (6) 6
antineoplastic agents - administration & dosage (6) 6
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
carcinoma, renal cell - metabolism (6) 6
disease progression (6) 6
double-blind (6) 6
everolimus (6) 6
genetic aspects (6) 6
imidazoles - therapeutic use (6) 6
in-vivo (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9807, pp. 1931 - 1939
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 7, pp. 917 - 927
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 6, pp. 552 - 562
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 3, pp. 293 - 300
Journal Article
Journal Article